Capricor places Duchenne drug trial on hold

Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy, a muscle-wasting disorder.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news